BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1759968)

  • 1. Changes in the hemostatic system and compensatory responses during alimentary hyperlipidemia.
    Lucio FJ; Puyol MR; Marques LD; Escribano CG; Duarte AM
    Biomed Biochim Acta; 1991; 50(7):893-9. PubMed ID: 1759968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of dietary short and long chain saturated fatty acids on platelet functions, platelet phospholipids, and blood coagulation in rats.
    McGregor L; Morazain R; Renaud S
    Lab Invest; 1980 Nov; 43(5):438-42. PubMed ID: 7421125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary hyperlipidemia-hypercholesterolemia on rat erythrocytes.
    de Lucio Cazana FJ; Rodriguez Puyol M; Perez-Caballero J; Jimenez Jimenez A; Montes Duarte A
    Int J Vitam Nutr Res; 1990; 60(4):392-7. PubMed ID: 2101832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental diabetes and platelet aggregation in the rat.
    Murray J; Kaneko JJ; Rucker RB
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):283-91. PubMed ID: 6356254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function.
    Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA
    Artery; 1993; 20(6):303-13. PubMed ID: 8010886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diet-induced hyperlipidemia on in vitro-function of rabbit platelets.
    Joist JH; Dolezel G; Kinlough-Rathbone R; Mustard JF
    Thromb Res; 1976 Nov; 9(5):435-45. PubMed ID: 996831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemostatic changes during pregnancy in reference to hyperlipidemia].
    Fuse Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jun; 40(6):714-20. PubMed ID: 3392435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia.
    Garzetti GG; Tranquilli AL; Cugini AM; Mazzanti L; Cester N; Romanini C
    Obstet Gynecol; 1993 Mar; 81(3):337-40. PubMed ID: 8437781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of membrane lipid composition, organization, and fluidity in human platelet function.
    Shattil SJ; Cooper RA
    Prog Hemost Thromb; 1978; 4():59-86. PubMed ID: 362482
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidemic activity of tincture of Crataegus in rats.
    Shanthi S; Parasakthy K; Deepalakshmi PD; Devaraj SN
    Indian J Biochem Biophys; 1994 Apr; 31(2):143-6. PubMed ID: 7927437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.
    Smith DJ; Gordon ER
    J Lab Clin Med; 1988 Dec; 112(6):679-85. PubMed ID: 3193023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in platelet aggregation kinetics in normal and hyperlipidemic rabbits.
    Suehiro A; Higashi T; Kakishita E; Nagai K
    Thromb Res; 1985 Jul; 39(2):195-202. PubMed ID: 4024053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.